High Grade Cervical Squamous Intraepithelial Neoplasia
2
0
0
1
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
3 treatments under study, led by Laboratory Biomarker Analysis
Research Leaders
8 sponsors active, led by National Cancer Institute (NCI)
Related Conditions
Often studied with 20 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
50.0%
1 terminated out of 2 trials
50.0%
-36.6% vs benchmark
50%
1 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer
Research Network
Common Treatments
- Laboratory Biomarker Analysis2
- Saline1
- Biospecimen Collection1
Active Sponsors
- National Cancer Institute (NCI)2
- AIDS and Cancer Specimen Resource1
- University of California, Los Angeles1
- AIDS Malignancy Consortium1
- M.D. Anderson Cancer Center1
Top Investigators
University of Witwatersrand, South Africa
M.D. Anderson Cancer Center
Related Conditions
- Stage Iva Cervical Cancer Ajcc V81
- Stage Ib1 Cervical Cancer Ajcc V81
- Cervical Squamous Intraepithelial Neoplasia1
- Vulvar Adenocarcinoma1
- Stage Ivb Cervical Cancer Ajcc V81